cepr center for economic and policy research promoting good ideas on drugs are patents the best way relative efficiency of patent public support bio medical by dean baker noriko chatani october 11 2002 washington dc 20009 202 293 5380 1 is co director briefing paper 1621 connecticut ave nw suite 500 www net email a associate executive summary widely publicized analysis pharmaceutical dimasi found that cost developing new rising far more rapidly than rate inflation its findings indicated costs had risen at 10 0 percent annually between 1987 2000 with development estimated 802 million per drug in as rise it becomes important to economy be carried through most efficient possible manner although nearly half biomedical spending united states supported either government or non profit
